Improving active case finding for tuberculosis in South Africa: informing innovative implementation approaches in the context of the Kharitode trial through formative research
Deanna Kerrigan(Milken Institute), David W. Dowdy(Johns Hopkins University), Nora West(University of California, San Francisco), Lesego Mmolawa(Perinatal HIV Research Unit), Neil Martinson(University of the Witwatersrand), Colleen F. Hanrahan(Johns Hopkins University), Carrie Tudor(International Council of Nurses), Reginah Msandiwa(University of the Witwatersrand), Limakatso Lebina(Perinatal HIV Research Unit)
Cited by 41
Related Papers
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
|JNCI Journal of the National Cancer Institute|2001|593
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
|New England Journal of Medicine|2024|471
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
|New England Journal of Medicine|2011|385